Understanding the miasmatic background of nasal polyp and effectiveness of lemna minor 6c in its treatment a prospective single arm pre post clinical study
Overview
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Bakson Homoeopathic Medical College and Hospital
- Enrollment
- 35
- Locations
- 1
- Primary Endpoint
- Changes will be observed on SNOT20 Score Scale
Overview
Brief Summary
This is a prospective single arm pre -post study ,to see the miasmatic background of nasal polyp and effectiveness of Lemna Minor 6c in cases of Nasal Polyp by using the SNOT 20 scale .
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 16.00 Year(s) to 45.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Both male and female will be included.
- •Participants diagnosed with nasal polyp Age group of 16 -45years suffering from nasal polyp will be included Participants who will be ready to give consent and assent.
- •Rhinoscopy findings of nasal polyp.
Exclusion Criteria
- •Participants on other medication Participants with other upper respiratory tract infections (laryngitis , pharyngitis , diphtheria ,etc) Pregnant and lactating female.
- •Uncontrolled systemic or psychiatric illness Participants with other respiratory infections (chronic bronchitis, bronchial Asthma ,cystic fibrosis Participants with suffering of sinusitis.
Outcomes
Primary Outcomes
Changes will be observed on SNOT20 Score Scale
Time Frame: SNOT20 SCORE Scale will be used at baseline, every 4 weeks upto 24 weeks. | 15 month study. | 6 months enrolment | 6 months follow up | 3 months analysis | first dose at the time of case taking and subsequent doses according to follow ups.
Changes can be positive or negative or no change
Time Frame: SNOT20 SCORE Scale will be used at baseline, every 4 weeks upto 24 weeks. | 15 month study. | 6 months enrolment | 6 months follow up | 3 months analysis | first dose at the time of case taking and subsequent doses according to follow ups.
Secondary Outcomes
No secondary outcomes reported
Investigators
Dr Annu Verma
Bakson homoeopathic medical college and hospital